TOP GUIDELINES OF ELIMUSERTIB

Pharmacological inhibition of the ataxia telangiectasia and Rad3-similar protein serine/threonine kinase (ATR; also known as FRAP-similar protein (FRP1)) has emerged for a promising method for most cancers remedy that exploits artificial lethal interactions with proteins linked to DNA hurt restore, overcomes resistance to other therapies and boosts